What is BTIG's price target for OTLK?

BTIG's latest stated price target for Outlook Therapeutics Inc. (OTLK) is $4, from its action on Jul 27, 2026.

What is BTIG's rating on OTLK?

BTIG rates OTLK Buy, a bullish rating, as of Jul 27, 2026.

When did BTIG last change its view on OTLK?

On Jul 27, 2026, BTIG upgrades to Buy from Neutral, price target $4.

BTIG OTLK price target and rating history

Outlook Therapeutics Inc. (OTLK) · Health Care

BTIG rates Outlook Therapeutics Inc. (OTLK) Buy with a $4 price target, as of its latest action on Jul 27, 2026. It has published 5 rating actions on OTLK since October 2022, including 2 upgrades and 2 downgrades.

Current rating: Buy
Price target: $4
Median target, all firms: Too few
Actions on OTLK: 5

BTIG price target on OTLK

BTIG price target on OTLK, each point a stated target, October 2022 to July 2026.

Every BTIG rating on OTLK

Jul 27, 2026
UpgradeBTIG upgrades to Buy from Neutral, price target $4
May 18, 2026
DowngradeBTIG downgrades to Neutral from Buy
Mar 27, 2024
UpgradeBTIG upgrades to Buy from Neutral, price target $50
Aug 30, 2023
DowngradeBTIG downgrades to Neutral from Buy
Oct 31, 2022
InitiateBTIG starts coverage at Buy, price target $7

Questions about BTIG and OTLK

What is BTIG's price target for OTLK?: BTIG's latest stated price target for Outlook Therapeutics Inc. (OTLK) is $4, from its action on Jul 27, 2026.
What is BTIG's rating on OTLK?: BTIG rates OTLK Buy, a bullish rating, as of Jul 27, 2026.
When did BTIG last change its view on OTLK?: On Jul 27, 2026, BTIG upgrades to Buy from Neutral, price target $4.

More OTLK rating histories

All BTIG ratings OTLK news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.